SUBSEQUENT EVENTS (Details) - USD ($)			9 Months Ended
	Aug. 07, 2019	Aug. 05, 2019	Jun. 30, 2019	Jun. 30, 2018	Sep. 30, 2018
Subsequent Event [Line Items]
Amount of convertible promissory note			$ 2,215,668		$ 1,586,631
Purchase price for assets acquired			$ 68,486	$ 269,520
Subsequent Event | Amendments to exclusive licensing and patent and know-how license and cooperation agreement | TheraCann International Benchmark Corporation
Subsequent Event [Line Items]
Amount of convertible promissory note		$ 1,000,000
Subsequent Event | Amendments to exclusive licensing and patent and know-how license and cooperation agreement | TheraCann International Benchmark Corporation | Convertible preferred stock
Subsequent Event [Line Items]
Value of stock issued		$ 4,000,000
Percentage of fixed-rate dividend yield		10.00%
Maturity of convertible promissory note		2 years
Threshold limit of private placement for full redemption /conversion of convertible preferred stock		$ 8,000,000
Subsequent Event | Asset Purchase Agreement | Vitatex, Inc | LineaRx, Inc.
Subsequent Event [Line Items]
Purchase price for assets acquired	$ 500,000
Initial payment at closing using common stock	300,000
Payments for issuance of common stock before September 30, 2019	100,000
Payments for issuance of common stock before December 31, 2019	100,000
Outstanding cash and/or equity obligations	11,710
Reduction in cash payment on outstanding cash and equity obligations	88,290
Additional performance-based equity distributions	500,000
Common stock due on occurrence of completing program filings on or before August 9, 2019	250,000
Threshold limit of Assets yield in gross revenue	100,000
Threshold limit of Assets yield in additional gross revenue	$ 200,000